Clinical Trial

Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders

Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
Safety, tolerability and efficacy of Descarte-08 in children, adolescents and young adults with childhood-onset systemic lupus erythematosus, ANCA-associated vasculitis, juvenile myasthenia gravis, and juvenile dermatomyositis
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2025-07-20; most recent amendment 2026-07-24.
Status change: Not Yet Recruiting → Recruiting 2026-01-08
Trial Details
NCT Number NCT07089121
Lead Sponsor Cartesian Therapeutics
Conditions Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV), Juvenile Myasthenia Gravis, Juvenile Dermatomyositis
Enrollment 50 participants
Start Date 2026-01-14
Primary Completion 2027-12 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-27